Issue navigation
Volume 23, Issue 2, April 2022
Articles
Surrogate-guided sampling designs for classification of rare outcomes from electronic medical records data
Biostatistics, Volume 23, Issue 2, April 2022, Pages 345–361, https://doi.org/10.1093/biostatistics/kxaa028
Individualized multi-omic pathway deviation scores using multiple factor analysis
Biostatistics, Volume 23, Issue 2, April 2022, Pages 362–379, https://doi.org/10.1093/biostatistics/kxaa029
General tests of the Markov property in multi-state models
Biostatistics, Volume 23, Issue 2, April 2022, Pages 380–396, https://doi.org/10.1093/biostatistics/kxaa030
A divide-and-conquer method for sparse risk prediction and evaluation
Biostatistics, Volume 23, Issue 2, April 2022, Pages 397–411, https://doi.org/10.1093/biostatistics/kxaa031
A sparse additive model for treatment effect-modifier selection
Biostatistics, Volume 23, Issue 2, April 2022, Pages 412–429, https://doi.org/10.1093/biostatistics/kxaa032
Adaptive treatment strategies for chronic conditions: shared-parameter G-estimation with an application to rheumatoid arthritis
Biostatistics, Volume 23, Issue 2, April 2022, Pages 430–448, https://doi.org/10.1093/biostatistics/kxaa033
The role of body mass index at diagnosis of colorectal cancer on Black–White disparities in survival: a density regression mediation approach
Biostatistics, Volume 23, Issue 2, April 2022, Pages 449–466, https://doi.org/10.1093/biostatistics/kxaa034
Bayesian sparse heritability analysis with high-dimensional neuroimaging phenotypes
Biostatistics, Volume 23, Issue 2, April 2022, Pages 467–484, https://doi.org/10.1093/biostatistics/kxaa035
Interim recruitment prediction for multi-center clinical trials
Biostatistics, Volume 23, Issue 2, April 2022, Pages 485–506, https://doi.org/10.1093/biostatistics/kxaa036
Immune correlates analysis using vaccinees from test negative designs
Biostatistics, Volume 23, Issue 2, April 2022, Pages 507–521, https://doi.org/10.1093/biostatistics/kxaa037
Fast Lasso method for large-scale and ultrahigh-dimensional Cox model with applications to UK Biobank
Biostatistics, Volume 23, Issue 2, April 2022, Pages 522–540, https://doi.org/10.1093/biostatistics/kxaa038
Evaluation of treatment effect modification by biomarkers measured pre- and post-randomization in the presence of non-monotone missingness
Biostatistics, Volume 23, Issue 2, April 2022, Pages 541–557, https://doi.org/10.1093/biostatistics/kxaa040
Bayesian analysis of longitudinal and multidimensional functional data
Biostatistics, Volume 23, Issue 2, April 2022, Pages 558–573, https://doi.org/10.1093/biostatistics/kxaa041
Integrative functional linear model for genome-wide association studies with multiple traits
Biostatistics, Volume 23, Issue 2, April 2022, Pages 574–590, https://doi.org/10.1093/biostatistics/kxaa043
Bayesian design of clinical trials using joint models for longitudinal and time-to-event data
Biostatistics, Volume 23, Issue 2, April 2022, Pages 591–608, https://doi.org/10.1093/biostatistics/kxaa044
An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting
Biostatistics, Volume 23, Issue 2, April 2022, Pages 609–625, https://doi.org/10.1093/biostatistics/kxaa045
Principal curve approaches for inferring 3D chromatin architecture
Biostatistics, Volume 23, Issue 2, April 2022, Pages 626–642, https://doi.org/10.1093/biostatistics/kxaa046
Dose–response modeling in high-throughput cancer drug screenings: an end-to-end approach
Biostatistics, Volume 23, Issue 2, April 2022, Pages 643–665, https://doi.org/10.1093/biostatistics/kxaa047
Quantifying diagnostic accuracy improvement of new biomarkers for competing risk outcomes
Biostatistics, Volume 23, Issue 2, April 2022, Pages 666–682, https://doi.org/10.1093/biostatistics/kxaa048
Corrigendum
Corrigendum to: Fast Lasso method for large-scale and ultrahigh-dimensional Cox model with applications to UK Biobank
Biostatistics, Volume 23, Issue 2, April 2022, Page 683, https://doi.org/10.1093/biostatistics/kxab019
